FOLH1 and prostate carcinoma: PSMA expression levels between model prostate cancer cell lines were quantified [Fig 1(a)] and visualized in vitro [Fig 1(b)] and ex vivo [Fig. 1(c)] to verify that biomarker levels were consistent following tumor xenograft growth in mouse models.